.RESEARCH EMPHASIZE.06 August 2024.
A huge randomized measured trial with cisgender ladies highlights the challenges of adherence to a regular oral preexposure prophylaxis routine and also demonstrates that twice-yearly shot of lenacapavir can easily preserve successful HIV protection degrees over 6 months.